课题基金 / 基金详情

项目摘要

项目成果

Amy Elizabeth Herr的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):关于微流体物理和化学的戈登研究会议(GRC)将于2009年6月29日至7月3日在意大利卢卡的Il Ciocco举行。Amy E.美国加州大学伯克利分校的教授和美国加州大学伯克利分校的教授胡安·G.斯坦福大学的圣地亚哥将与副主席James P. Landers教授(弗吉尼亚大学)和Brian J. Kirby教授(康奈尔大学)共同担任会议主席。会议将包括纳米生物技术前沿会议,用于研究单分子的微流体工具,即时诊断,微/纳米系统运输,能源,微流体启用的系统生物学和疾病生物标志物发现。我们希望为一部分与会者的会议注册和/或差旅费提供财政支持,特别考虑初级研究人员(即,学生,博士后研究人员)。这个物理和化学的微流体GRC是重要的,因为以讨论为导向的论坛为科学家和工程师提供了一个独特的机会,专注于技术在推进生物医学科学中的作用。这种应用的健康相关性在于,微流体和纳米流体技术为研究健康和疾病过程的生物分子相互作用提供了新的工具。详细的,甚至是定量的知识对于理解疾病的分子基础和开发新的治疗方法至关重要。虽然少数会议没有专门讨论NIBIB和NIGMS方案(即,能源),微流体和微工程是强大的技术,可用于促进和显着改善基础和应用生物医学研究;主题领域,包括会议的主要焦点。微流体和纳米技术是高度多学科的领域。基于我们以前成功的GRC(自2001年以来每两年一次),参与者将具有不同的背景(生物工程,化学,生物学,物理学,化学工程,电气工程,机械工程,医学和材料科学)。与会者将代表学术界、政府和工业界,其中大多数与会者来自学术界。本次会议的一个主要目标是鼓励来自不同背景的参与者之间的互动,以促进微流体技术的成熟,帮助阐明复杂的生物学问题。 这种应用的健康相关性在于,微流体和纳米流体技术为研究健康和疾病过程的生物分子相互作用提供了新的工具。在提案中详细说明,定量知识对于理解疾病的分子基础和开发新疗法至关重要。微流体和微工程是强大的技术,可用于促进和显着改善基础和应用生物医学研究;主题领域,包括会议的主要焦点。
英文摘要
DESCRIPTION (provided by the applicant): The Gordon Research Conference (GRC) on the Physics and Chemistry of Microfluidics will be held from June 29th to July 3rd, 2009 at Il Ciocco in Lucca, Italy. Prof. Amy E. Herr of the University of California, Berkeley and Prof. Juan G. Santiago of Stanford University will act as co-Chairs for the conference with vice-Chairs Prof. James P. Landers (University of Virginia) and Prof. Brian J. Kirby (Cornell University). The conference will include sessions on Frontiers in Nanobiotechnology, Microfluidic Tools for Studying Single Molecules, Point-of-care Diagnostics, Transport in Micro/Nanoscale Systems, Energy, Systems Biology Enabled by Microfluidics, and Disease Biomarker Discovery. We hope to give financial support toward conference registration and/or travel costs for a subset of attendees, giving special consideration to junior investigators (i.e., students, postdoctoral researchers). This Physics and Chemistry of Microfluidics GRC is significant, as the discussion-oriented forum provides a unique opportunity for scientists and engineers to focus on the role of technology in advancing biomedical science. The health-relatedness of this application lies in the fact that microfluidic and nanofluidic technologies are providing new tools to study biomolecular interactions that underlie health and disease processes. A detailed, even quantitative knowledge is critical for understanding the molecular basis of disease and developing new therapies. While a handful of sessions do not specifically address NIBIB and NIGMS programs (i.e., Energy), microfluidics and microengineering are powerful technologies that can be used to facilitate and dramatically improve basic and applied biomedical research; topical areas that comprise the major focus of the conference. Microfluidics and nanotechnology is highly multidisciplinary fields. Based on our previous successful GRC's (biennially since 2001), participants will have diverse backgrounds (bioengineering, chemistry, biology, physics, chemical engineering, electrical engineering, mechanical engineering, medicine, and materials science). Participants will represent academia, government, and industry with the majority of participants from the academic sector. A main goal of this conference is to encourage interaction among participants from dissimilar backgrounds in order to facilitate the maturation of microfluidic technologies to help elucidate complex biological problems. The health-relatedness of this application lies in the fact that microfluidic and nanofluidic technologies are providing new tools to study biomolecular interactions that underlie health and disease processes. A detailed in the proposal, quantitative knowledge is critical for understanding the molecular basis of disease and developing new therapies. Microfluidics and microengineering are powerful technologies that can be used to facilitate and dramatically improve basic and applied biomedical research; topical areas that comprise the major focus of the conference.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MULTIPLEXED ISOFORM QUANTIFICATION IN HER2-POSITIVE BREAST CANCER
  • 批准号:
    10362550
  • 项目类别:
  • 资助金额:
    $34.53万
  • 财政年份:
    2021
  • 负责人:
    Amy Elizabeth Herr
  • 依托单位:
MULTIPLEXED ISOFORM QUANTIFICATION IN HER2-POSITIVE BREAST CANCER
  • 批准号:
    10583566
  • 项目类别:
  • 资助金额:
    $35.05万
  • 财政年份:
    2021
  • 负责人:
    Amy Elizabeth Herr
  • 依托单位:
Advanced Cancer Classification via Single-Cell Electrophoretic Cytopathology
  • 批准号:
    9482979
  • 项目类别:
  • 资助金额:
    $145.39万
  • 财政年份:
    2017
  • 负责人:
    Amy Elizabeth Herr
  • 依托单位:
Multiplexed isoform quantification in HER2-positive breast cancer
  • 批准号:
    9390766
  • 项目类别:
  • 资助金额:
    $34.78万
  • 财政年份:
    2015
  • 负责人:
    Amy Elizabeth Herr
  • 依托单位:
海外基金